is nembutal a depressant Options
is nembutal a depressant Options
Blog Article
pentobarbital will decrease the extent or influence of isavuconazonium sulfate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will lessen the extent or influence of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Avoid coadministration. Sturdy or moderate CYP3A inducers might lower cobimetinib systemic exposure by >eighty% and decrease its efficacy.
pentobarbital and daridorexant both maximize sedation. Modify Therapy/Observe Intently. Coadministration boosts possibility of CNS despair, which can result in additive impairment of psychomotor functionality and trigger daytime impairment.
pentobarbital will decrease the extent or impact of efavirenz by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Mysterious.
pentobarbital will minimize the extent or result of voriconazole by impacting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unidentified.
Likely for Untrue optimistic exam results if macimorelin and powerful CYP3A4 inducers are coadministered. Discontinue robust CYP3A4 inducer, permitting for ample washout time, just before tests.
pentobarbital will improve the amount or result of clopidogrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Observe Intently (1)pentobarbital will decrease the level or outcome of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or outcome of vinblastine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar.
pentobarbital will decrease the extent or impact of artemether/lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with solid CYP3A4 inducers may end up in reduced serum concentrations and loss of antimalarial efficacy
pentobarbital will minimize the level or result of diazepam intranasal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Potent or reasonable CYP3A4 inducers may well increase fee of diazepam elimination; therefore, efficacy of diazepam might be reduced.
pentobarbital will minimize the extent website or impact of fostemsavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Might produce loss of virologic response and probable resistance.
pentobarbital will lessen the extent or impact of eltrombopag by influencing hepatic enzyme CYP2C9/ten metabolism. Use Warning/Check.